Cosmos Health Statistics
Total Valuation
Cosmos Health has a market cap or net worth of $19.27 million. The enterprise value is $38.48 million.
Important Dates
The last earnings date was Wednesday, April 15, 2026, before market open.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cosmos Health has 50.74 million shares outstanding. The number of shares has increased by 58.19% in one year.
| Current Share Class | 50.74M |
| Shares Outstanding | 50.74M |
| Shares Change (YoY) | +58.19% |
| Shares Change (QoQ) | +16.50% |
| Owned by Insiders (%) | 26.59% |
| Owned by Institutions (%) | 5.95% |
| Float | 37.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 4.75 |
| PS Ratio | 0.30 |
| Forward PS | 0.18 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 1.08.
| Current Ratio | 1.00 |
| Quick Ratio | 0.61 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.31 |
Financial Efficiency
Return on equity (ROE) is -89.13% and return on invested capital (ROIC) is -40.88%.
| Return on Equity (ROE) | -89.13% |
| Return on Assets (ROA) | -17.26% |
| Return on Invested Capital (ROIC) | -40.88% |
| Return on Capital Employed (ROCE) | -60.80% |
| Weighted Average Cost of Capital (WACC) | 19.41% |
| Revenue Per Employee | $438,066 |
| Profits Per Employee | -$128,490 |
| Employee Count | 149 |
| Asset Turnover | 1.09 |
| Inventory Turnover | 11.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.05% in the last 52 weeks. The beta is 4.46, so Cosmos Health's price volatility has been higher than the market average.
| Beta (5Y) | 4.46 |
| 52-Week Price Change | -5.05% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.63 |
| Relative Strength Index (RSI) | 56.24 |
| Average Volume (20 Days) | 1,397,651 |
Short Selling Information
The latest short interest is 159,819, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 159,819 |
| Short Previous Month | 149,459 |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.43% |
| Short Ratio (days to cover) | 0.42 |
Income Statement
In the last 12 months, Cosmos Health had revenue of $65.27 million and -$19.14 million in losses. Loss per share was -$0.63.
| Revenue | 65.27M |
| Gross Profit | 7.90M |
| Operating Income | -16.54M |
| Pretax Income | -19.14M |
| Net Income | -19.14M |
| EBITDA | -15.18M |
| EBIT | -16.54M |
| Loss Per Share | -$0.63 |
Full Income StatementBalance Sheet
The company has $761,832 in cash and $19.97 million in debt, with a net cash position of -$19.21 million or -$0.38 per share.
| Cash & Cash Equivalents | 761,832 |
| Total Debt | 19.97M |
| Net Cash | -19.21M |
| Net Cash Per Share | -$0.38 |
| Equity (Book Value) | 18.42M |
| Book Value Per Share | 0.45 |
| Working Capital | 116,412 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.45 million and capital expenditures -$55,675, giving a free cash flow of -$8.50 million.
| Operating Cash Flow | -8.45M |
| Capital Expenditures | -55,675 |
| Depreciation & Amortization | 1.36M |
| Net Borrowing | 10.47M |
| Free Cash Flow | -8.50M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
Gross margin is 12.10%, with operating and profit margins of -25.34% and -29.33%.
| Gross Margin | 12.10% |
| Operating Margin | -25.34% |
| Pretax Margin | -29.33% |
| Profit Margin | -29.33% |
| EBITDA Margin | -23.26% |
| EBIT Margin | -25.34% |
| FCF Margin | n/a |
Dividends & Yields
Cosmos Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.19% |
| Shareholder Yield | -58.19% |
| Earnings Yield | -99.35% |
| FCF Yield | -44.13% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 16, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Dec 16, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
Cosmos Health has an Altman Z-Score of -2.45 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.45 |
| Piotroski F-Score | 4 |
